Pioneering RF energy, Dielectric Barrier Discharge (DBD) technology for modern medicine

General Vibronics, Inc. is a U.S. medical device company advancing Radiofrequency (RF) technology for clinical applications worldwide. At the core of the MIRARI® Cold Plasma System lies a sophisticated application of RF technology. Radiofrequency energy has been used in medicine for decades, but the MIRARI® Cold Plasma System takes it to new heights by employing a combination of advanced features designed to optimize its therapeutic potential.

Watch our corporate video Learn More
FDA Cleared

The MIRARI® Cold Plasma System designed and manufactured by General Vibronics, received U.S. FDA 510(k) clearance, establishing it as a Class II medical device authorized for U.S. market distribution.

About General Vibronics

General Vibronics, Inc. is a medical device company headquartered in Tempe, Arizona. We design, develop, and commercialize MIRARI® Cold Plasma System, providing healthcare professionals with an FDA 510(k) Cleared, non-invasive treatment modality.
Our flagship product, the MIRARI® Cold Plasma System, is the result of years of research at the intersection of plasma physics, biomedical engineering, and clinical medicine. It is cleared by the U.S. FDA, approved by the Thai FDA, and registered with the Vietnam Ministry of Health.
About General Vibronics
General Vibronics Office

MIRARI® Cold Plasma System

An FDA-cleared, handheld therapeutic platform that utilizes Dielectric Barrier Discharge (DBD) technology with 80 kHz monopolar radiofrequency energy. The MIRARI® is indicated for heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms and increase in local circulation.

“
"If you want to find the secrets of the universe, think in terms of energy, frequency and vibration."
Nikola Tesla
Inventor, Electrical Engineer, Futurist

Over a century ago, Tesla envisioned healing through energy, and vibrational frequencies. Today, MIRARI® Cold Plasma System brings that vision to life.

Nikola Tesla

The world's first handheld MIRARI® Cold Plasma System

Play VideoIntroduction
FDA 510(k) Cleared(Class II)
1200 minsPlasma array run time
DMEDurable Medical Equipment
MIRARI® Cold Plasma System

Regulatory & Recognition

U.S. FDA U.S. FDA 510(k) Cleared (Class II)
Thai FDA Thai FDA Approved & Registered
Vietnam MOH Vietnam MOH Registered Medical Device
ISO 13485:2016 ISO 13485:2016 Certified QMS
JWC Award 2017

Best Innovation in North America

Journal of Wound Care (JWC)

March 2017 London, UK
WUWHS Best Poster 2016

Best Poster Award

World Union of Wound Healing Societies (WUWHS)

September 2016 Florence, Italy

Our Partners

CSQ Bio - USA Mirari Doctor Mirari Thailand Mirari Vietnam
International Scientific Seminar on MIRARI® Cold Plasma System
Organization Logo 1 Organization Logo 2
Official Announcement

International Scientific Seminar on MIRARI® Cold Plasma System

On March 7, 2026, the Vietnam University of Traditional Medicine (VUTM) officially convened a landmark seminar in Hanoi to evaluate the safety and efficacy of Mirari Cold Plasma. This Ministry of Health-authorized event marks a new era for non-invasive treatments, with Tue Tinh Hospital pioneering clinical applications for optimized patient recovery.

Learn More

Latest News

Cold Plasma Therapy Reaches Vietnam’s War Veterans in Community Health Outreach Near Hanoi Apr 2026

Cold Plasma Therapy Reaches Vietnam’s War Veterans in Community Health Outreach Near Hanoi

News
Hanoi’s Hospital E Convenes Cold Plasma Summit Amid Rising Evidence for Antibiotic-Free Wound Care Apr 2026

Hanoi’s Hospital E Convenes Cold Plasma Summit Amid Rising Evidence for Antibiotic-Free Wound Care

News
From Lab to Bedside: How Five Generations of MIRARI® Cold Plasma Technology Led to FDA Clearance Apr 2026

From Lab to Bedside: How Five Generations of MIRARI® Cold Plasma Technology Led to FDA Clearance

News
View All News